PROTOCOL REVIEW AND MONITORING SYSTEM
PROTOCOL REVIEW AND MONITORING SYSTEM
批准号:
8486658
负责人:
MICHELLE M LE BEAU
金额:
$6.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-01 至 2018-03-31
关键词:
AdherenceAdvisory CommitteesCancer Center Support GrantChargeChicagoClinicalClinical ResearchClinical SciencesClinical TrialsComprehensive Cancer CenterConduct Clinical TrialsDataDisciplineDiseaseEnsureEthicsFacultyGoalsGuidelinesIndividualInformaticsInformation SystemsInstitutional Review BoardsInstructionMalignant NeoplasmsMinorityMonitorPeer ReviewProceduresProtocols documentationRecommendationRegistriesRelative (related person)Research InfrastructureResearch PersonnelResourcesReview CommitteeRoleSafetyScientific EvaluationSystemUnited States National Institutes of HealthUniversitiesauthoritybasecancer research center directordesignexpedited reviewexperiencemeetingsmemberoperationprogramssound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (See instructions): The purpose of the Protocol Review and Monitoring System (PRMS) is to review the scientific merit, scientific priorities, and scientific progress of cancer-related studies that are conducted at the University of Chicago, regardless of sponsor, department or type, and that use the University of Chicago Comprehensive Cancer Center (UCCCC) resources. The UCCCC PRMS is divided into two committees, the Clinical Trials Review Committee (CTRC), and the Scientific and Accrual Monitoring (SAM) Committee, which are overseen by the Associate Director for Clinical Sciences (Dr. Mark Ratain) and the Clinical Research Advisory Committee (CRAC). A single Coordinator serves all three committees. The CTRC and SAM are composed of UCCCC members from all academic units and disciplines who have expertise in clinical trials. The CTRC meets monthly, and has primary responsibility for evaluation of the scientific merit, rigor, appropriateness of data and safety monitoring, and the relative prioritization of trials in the context of UCCCC and disease-specific program goals and resources. CTRC and IRB review occur simultaneously, but protocol activation requires full CTRC approval. CTRC reviews are conducted by at least 3 individuals, including a biostatistician. Protocols may be approved, approved with revisions, deferred, or disapproved. Protocols that have undergone prior peer review (e.g., cooperative group protocols, NIH, ACS) and strict banking/registry studies are eligible for expedited review; that is, they are not required to be reviewed by the full committee, but rather will be reviewed by the Chair or Co-chair who have the option of bringing them to the full committee if there are specific concerns (e.g., design, prioritization). In addition, CTRC has the authority to close protocols based on the recommendation of the SAM Committee. Specifically, the SAM Committee has primary responsibility for monitoring the scientific progress of CTRC-approved studies including accrual, minority accrual, and overall progress towards meeting the study's objectives, as well as ensuring adherence to protocol procedures and UCCCC Data and Safety Monitoring requirements. The SAM Committee meets monthly, and recommends closure of protocols that are not making adequate scientific progress, or that are not meeting adequate scientific or Data and Safety Monitoring guidelines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanisms of myeloid suppressor genes on chromosome 5
-
批准号:8997482
-
项目类别:
-
资助金额:$36.14万
-
财政年份:2015
-
负责人:MICHELLE M LE BEAU
-
依托单位:
Molecular mechanisms of myeloid suppressor genes on chromosome 5
-
批准号:8797860
-
项目类别:
-
资助金额:$36.14万
-
财政年份:2015
-
负责人:MICHELLE M LE BEAU
-
依托单位:
Registration and Submission of Clinical Trials Data
-
批准号:8744809
-
项目类别:
-
资助金额:$7.64万
-
财政年份:2014
-
负责人:MICHELLE M LE BEAU
-
依托单位:
ADMINISTRATION
-
批准号:8744848
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2014
-
负责人:MICHELLE M LE BEAU
-
依托单位:
MOLECULAR MECHANISM OF CANCER
-
批准号:8486598
-
项目类别:
-
资助金额:$2.33万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
CANCER PREVENTION AND CONTROL
-
批准号:8486618
-
项目类别:
-
资助金额:$2.29万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
CANCER CLINICAL TRIALS OFFICE
-
批准号:8486649
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
CYTOMETRY AND ANTIBODY TECHNOLOGY
-
批准号:8486626
-
项目类别:
-
资助金额:$12.84万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
HUMAN IMMUNOLOGIC MONITORING AND CGMP
-
批准号:8486629
-
项目类别:
-
资助金额:$12.77万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
GENOMICS
-
批准号:8486625
-
项目类别:
-
资助金额:$19.42万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
DEVELOPMENTAL FUNDS
-
批准号:8486665
-
项目类别:
-
资助金额:$29.19万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
IMMUNOLOGY AND CANCER
-
批准号:8486612
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
HEMATOPOIESIS AND HEMATOLOGICAL MALIGNANCIES
-
批准号:8486610
-
项目类别:
-
资助金额:$2.75万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
PHARMACOLOGY
-
批准号:8486644
-
项目类别:
-
资助金额:$7.17万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
INTEGRATED SMALL ANIMAL IMAGING RESEARCH RESOURCE
-
批准号:8486636
-
项目类别:
-
资助金额:$11.43万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
PROTOCOL-SPECIFIC RESEARCH SUPPORT
-
批准号:8486660
-
项目类别:
-
资助金额:$6.11万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
IMAGE COMPUTING, ANALYSIS AND REPOSITORY
-
批准号:8486640
-
项目类别:
-
资助金额:$7.88万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
Registration and Submission of Clinical Trials Data
-
批准号:8744808
-
项目类别:
-
资助金额:$3.75万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
SENIOR LEADERSHIP
-
批准号:8486663
-
项目类别:
-
资助金额:$21.92万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
HUMAN TISSUE RESOURCE CENTER
-
批准号:8486643
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2013
-
负责人:MICHELLE M LE BEAU
-
依托单位:
海外基金